(Q51027167)

27 March 2018

title

The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia. (English)

1 reference

27 March 2018

dementia with Lewy bodies

0 references

1 reference

1 reference

1 reference

2

H Zetterberg

1 reference

27 March 2018

4

K Blennow

1 reference

27 March 2018

5

E Londos

1 reference

27 March 2018

Lennart Minthon

series ordinal

3

object named as

L Minthon

1 reference

27 March 2018

author name string

M Andersson

series ordinal

1

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 January 2011

1 reference

27 March 2018

International Journal of Geriatric Psychiatry

published in

1 reference

27 March 2018

volume

26

1 reference

27 March 2018

issue

1

1 reference

27 March 2018

page(s)

100-105

1 reference

27 March 2018

Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.

cites work

1 reference

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies

21 January 2018

1 reference

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies

21 January 2018

1 reference

Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

21 January 2018

1 reference

7 January 2021

Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

1 reference

7 January 2021

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

1 reference

7 January 2021

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

1 reference

7 January 2021

Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.

1 reference

7 January 2021

Clinical diagnostic criteria for dementia associated with Parkinson's disease

1 reference

7 January 2021

1 reference

7 January 2021

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease

1 reference

7 January 2021

Differentiation of dementia with Lewy bodies from Alzheimer's disease using Mini-Mental State Examination and brain perfusion SPECT.

1 reference

7 January 2021

Predictors of survival in dementia with lewy bodies and Parkinson dementia

1 reference

7 January 2021

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies

1 reference

7 January 2021

Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both

1 reference

7 January 2021

Cortical alpha-synuclein load is associated with amyloid-beta plaque burden in a subset of Parkinson's disease patients

1 reference

7 January 2021

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

1 reference

7 January 2021

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

7 January 2021

Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies.

1 reference

7 January 2021

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

1 reference

7 January 2021

CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.

1 reference

7 January 2021

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

1 reference

7 January 2021

The Mini-Mental State exam may help in the differentiation of dementia with Lewy bodies and Alzheimer's disease

1 reference

7 January 2021

Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.

1 reference

7 January 2021

Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.

1 reference

7 January 2021

Index for rating diagnostic tests

1 reference

7 January 2021

A systematic review of prevalence and incidence studies of dementia with Lewy bodies

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.2496

1 reference

27 March 2018

1 reference

27 March 2018